Detail Information of Microbiota Influence

General Information of Drug Transporter (DT)
DT ID DTD0060 Transporter Info
Gene Name ABCC7
Transporter Name Cystic fibrosis transmembrane conductance regulator
Gene ID
1080
UniProt ID
P13569
Microbiota Influence of This DT (MBI)

Bacteria: Bacillota

   Genus: Lacticaseibacillus

     Lacticaseibacillus casei 

Microbe Info

Click to Show/Hide the Full List 1 Microbe Influence Related to This Species      

       Microbe Influence 1

 Up regulating of ABCC7 expression in type 2 diabetes mellitus condition [1]

Studied Phenotype

 Type 2 diabetes mellitus [ICD11: 5A11]

Studied Tissue

 Heart

In Vivo Model

 Sprague-Dawley rats

Detailed Description

 The Lacticaseibacillus casei str. Zhang has been reported to increase the expression of the drug transporter ABCC7.

Bacteria: Pseudomonadota

   Genus: Escherichia

     Escherichia coli 

Microbe Info

Click to Show/Hide the Full List 2 Microbe Influence Related to This Species      

       Microbe Influence 1

 Up regulating of ABCC7 expression in mastitis condition [2]

Regulating Factor
Lipopolysaccharide

Studied Phenotype

 Mastitis [ICD11: GB21]

Studied Tissue

 Breast

In Vivo Model

 ICR mice

Detailed Description

 The compound Lipopolysaccharide Generated by Escherichia coli O111:B4 has been reported to increase the expression of the drug transporter ABCC7.

       Microbe Influence 2

 Up regulating of ABCC7 expression in diarrhea associated with infection by invasive enteric pathogens condition [3] , [4]

Studied Phenotype

 Diarrhea associated with infection by invasive enteric pathogens [ICD11: 1A03]

Studied Tissue

 Colon

In Vitro Model

 Human colon adenocarcinoma cells (HT29-Cl.19A)

Detailed Description

 The Escherichia coli O29 has been reported to increase the expression of the drug transporter ABCC7.

   Genus: Salmonella

     Salmonella enterica 

Microbe Info

Click to Show/Hide the Full List 2 Microbe Influence Related to This Species      

       Microbe Influence 1

 Activation of ABCC7 in typhoid condition [5] , [6]

Regulating Factor
Lipopolysaccharide

Studied Phenotype

 Typhoid fever [ICD11: 1A07]

Studied Tissue

 Lung

In Vivo Model

 C57BL/6 mice

In Vitro Model

 Human cystic fibrosis cells (CFT1-LCFSN)

Detailed Description

 The compound Lipopolysaccharide Generated by Salmonella enterica subsp. enterica serovar Typhi str. Ty2 has been reported to activate the function of the drug transporter ABCC7.

       Microbe Influence 2

 Up regulating of ABCC7 expression in diarrhea associated with infection by invasive enteric pathogens condition [3] , [4]

Studied Phenotype

 Diarrhea associated with infection by invasive enteric pathogens [ICD11: 1A03]

Studied Tissue

 Colon

In Vitro Model

 Human colon adenocarcinoma cells (HT29-Cl.19A)

Detailed Description

 The Salmonella enterica subsp. enterica serovar Dublin has been reported to increase the expression of the drug transporter ABCC7.

Bacteria: Host unspecified microbiota

   Genus: Unknown microbiota

     Host unspecified microbiota 

Click to Show/Hide the Full List 2 Microbe Influence Related to This Species      

       Microbe Influence 1

 Down regulating of ABCC7 expression in the health condition [7] , [8]

Regulating Factor
Trimethylamine oxide

Studied Tissue

 Liver

In Vivo Model

 C57BL/6J mice

Detailed Description

 The metabolite trimethylamine oxide generated from the metabolism of l-carnitine by the host unspecified microbiota has been reported to decrease the expression of the drug transporter ABCC7.

       Microbe Influence 2

 Down regulating of ABCC7 expression in fatal diarrhea/infections with enteropathogenic E. coli/infections with enterohemorrhagic E. coli condition [9] , [10]

Studied Phenotype

 Fatal diarrhea/infections with enteropathogenic Escherichia coli [ICD11: 1A03]

Studied Tissue

 Colon

In Vivo Model

 FVB/N mice

Detailed Description

 The host unspecified microbiota has been reported to decrease the expression of the drug transporter ABCC7.
References
1 Lactobacillus casei reduces susceptibility to type 2 diabetes via microbiota-mediated body chloride ion influx. Sci Rep. 2014 Jul 18;4:5654.
2 Underlying mechanisms involved in the decrease of milk secretion during Escherichia coli endotoxin induced mastitis in lactating mice. Vet Res. 2013 Dec 5;44(1):119.
3 The Role of Ion Transporters in the Pathophysiology of Infectious Diarrhea. Cell Mol Gastroenterol Hepatol. 2018 Mar 5;6(1):33-45.
4 Enteroinvasive bacteria alter barrier and transport properties of human intestinal epithelium: role of iNOS and COX-2. Gastroenterology. 2002 Apr;122(4):1070-87.
5 The interaction of gut microbes with host ABC transporters. Gut Microbes. 2010 Sep;1(5):301-306.
6 Salmonella enterica serovar typhi modulates cell surface expression of its receptor, the cystic fibrosis transmembrane conductance regulator, on the intestinal epithelium. Infect Immun. 2002 Nov;70(11):6416-23.
7 Gut Microbiome and Response to Cardiovascular Drugs. Circ Genom Precis Med. 2019 Sep;12(9):421-429.
8 Intestinal microbiota metabolism of L-carnitine, a nutrient in red meat, promotes atherosclerosis. Nat Med. 2013 May;19(5):576-85.
9 Colonic microbiota alters host susceptibility to infectious colitis by modulating inflammation, redox status, and ion transporter gene expression. Am J Physiol Gastrointest Liver Physiol. 2011 Jul;301(1):G39-49.
10 Decreased expression of colonic Slc26a3 and carbonic anhydrase iv as a cause of fatal infectious diarrhea in mice. Infect Immun. 2009 Sep;77(9):3639-50.

If you find any error in data or bug in web service, please kindly report it to Dr. Yin and Dr. Li.